NITRASE THERAPEUTICS
Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is on Parkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
NITRASE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Jackson, Mississippi, United States
Country:
United States
Website Url:
http://www.nitrasetx.com
Total Employee:
1+
Status:
Active
Contact:
4153101058
Total Funding:
45.1 M USD
Technology used in webpage:
Google Maps
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Be Biopharma
Be Biopharma is developing B ceaBe Biopharma is a biotech research company that develops a class of B cells as medicines.lls as medicines.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Nitrase Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics
Bristol Myers Squibb
Bristol Myers Squibb investment in Series A - Nitrase Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Nitrase Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series A - Nitrase Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Nitrase Therapeutics
Mission Bay Capital
Mission Bay Capital investment in Series A - Nitrase Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Nitrase Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Nitrase Therapeutics
Official Site Inspections
http://www.nitrasetx.com Semrush global rank: 5.7 M Semrush visits lastest month: 1.47 K
- Host name: 170.6.212.35.bc.googleusercontent.com
- IP address: 35.212.6.170
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
